Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities

被引：360

作者：

Davis, Ryan J. ^{[1
,2
,3
]}

Welcker, Markus ^{[1
,2
]}

Clurman, Bruce E. ^{[1
,2
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA

[2] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA

[3] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA

来源：

CANCER CELL | 2014年 / 26卷 / 04期

基金：

美国国家科学基金会;

关键词：

F-BOX PROTEIN; ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL DIFFERENTIATION; FBXW7; BETA-FORM; CYCLIN-E; C-MYC; DEPENDENT DEGRADATION; PROMOTER HYPERMETHYLATION; MULTISITE PHOSPHORYLATION; SUBSTRATE RECOGNITION;

D O I：

10.1016/j.ccell.2014.09.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Tumor suppressors with widespread impact on carcinogenesis control broad spectra of oncogenic pathways. Protein degradation is an emerging mechanism by which tumor suppressors regulate a diversity of pathways and is exemplified by the SCFFbw7 ubiquitin ligase. Rapidly accumulating data indicate that SCFFbw7 regulates a network of crucial oncoproteins. Importantly, the FBXW7 gene, which encodes Fbw7, is one of the most frequently mutated genes in human cancers. These studies are yielding important new insights into tumorigenesis and may soon enable therapies targeting the Fbw7 pathway. Here, we focus on the mechanisms and consequences of Fbw7 deregulation in cancers and discuss possible therapeutic approaches.

引用

收藏

页码：455 / 464

页数：10

相关论文

共 101 条

[1]

FBXW7/hCDC4 is a general tumor suppressor in human cancer [J].

Akhoondi, Shahab ;

Sun, Dahui ;

von der Lehr, Natalie ;

Apostolidou, Sophia ;

Klotz, Kathleen ;

Maljukova, Alena ;

Cepeda, Diana ;

Fiegl, Heidi ;

Dofou, Dimitra ;

Marth, Christian ;

Mueller-Holzner, Elisabeth ;

Corcoran, Martin ;

Dagnell, Markus ;

Nejad, Sepideh Zabihi ;

Nayer, Babak Noori ;

Zali, Mohammad Reza ;

Hansson, Johan ;

Egyhazi, Susanne ;

Petersson, Fredrik ;

Sangfelt, Per ;

Nordgren, Hans ;

Grander, Dan ;

Reed, Steven I. ;

Widschwendter, Martin ;

Sangfelt, Olle ;

Spruck, Charles .

CANCER RESEARCH, 2007, 67 (19) :9006-9012

[2]

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer [J].

Akhoondi, Shahab ;

Lindstrom, Linda ;

Widschwendter, Martin ;

Corcoran, Martin ;

Bergh, Jonas ;

Spruck, Charles ;

Grander, Dan ;

Sangfelt, Olle .

BREAST CANCER RESEARCH, 2010, 12 (06)

[3]

FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation [J].

Babaei-Jadidi, Roya ;

Li, Ningning ;

Saadeddin, Anas ;

Spencer-Dene, Bradley ;

Jandke, Anett ;

Muhammad, Belal ;

Ibrahim, ElSayed E. ;

Muraleedharan, Ranjithmenon ;

Abuzinadah, Mohammed ;

Davis, Hayley ;

Lewis, Annabelle ;

Watson, Susan ;

Behrens, Axel ;

Tomlinson, Ian ;

Nateri, Abdolrahman Shams .

JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (02) :295-312

[4]

c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover [J].

Bahram, F ;

von der Lehr, N ;

Cetinkaya, C ;

Larsson, LG .

BLOOD, 2000, 95 (06) :2104-2110

[5]

FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4 [J].

Balamurugan, Kuppusamy ;

Sharan, Shikha ;

Klarmann, Kimberly D. ;

Zhang, Youhong ;

Coppola, Vincenzo ;

Summers, Glenn H. ;

Roger, Thierry ;

Morrison, Deborah K. ;

Keller, Jonathan R. ;

Sterneck, Esta .

NATURE COMMUNICATIONS, 2013, 4

[6]

Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation [J].

Bengoechea-Alonso, M. T. ;

Ericsson, J. .

ONCOGENE, 2010, 29 (38) :5322-5328

[7]

The ubiquitin ligase Fbxw7 controls adipocyte differentiation by targeting C/EBPα for degradation [J].

Bengoechea-Alonso, Maria T. ;

Ericsson, Johan .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (26) :11817-11822

[8]

POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS [J].

BHATIA, K ;

HUPPI, K ;

SPANGLER, G ;

SIWARSKI, D ;

IYER, R ;

MAGRATH, I .

NATURE GENETICS, 1993, 5 (01) :56-61

[9]

A Colon Cancer-derived Mutant of Kruppel-like Factor 5 (KLF5) Is Resistant to Degradation by Glycogen Synthase Kinase 3β (GSK3β) and the E3 Ubiquitin Ligase F-box and WD Repeat Domain-containing 7α (FBW7α) [J].

Bialkowska, Agnieszka B. ;

Liu, Yang ;

Nandan, Mandayam O. ;

Yang, Vincent W. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (09) :5997-6005

[10]

Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7γ [J].

Bonetti, Paola ;

Davoli, Teresa ;

Sironi, Cristina ;

Amati, Bruno ;

Pelicci, Pier Giuseppe ;

Colombo, Emanuela .

JOURNAL OF CELL BIOLOGY, 2008, 182 (01) :19-26

← 1 2 3 4 5 6 7 8 9 10 →